Cargando…
Bacteria as Nanoparticle Carriers for Immunotherapy in Oncology
The use of nanocarriers to deliver antitumor agents to solid tumors must overcome biological barriers in order to provide effective clinical responses. Once within the tumor, a nanocarrier should navigate into a dense extracellular matrix, overcoming intratumoral pressure to push it out of the disea...
Autores principales: | Moreno, Víctor M., Baeza, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027800/ https://www.ncbi.nlm.nih.gov/pubmed/35456618 http://dx.doi.org/10.3390/pharmaceutics14040784 |
Ejemplares similares
-
Tumor Targeted Nanocarriers for Immunotherapy
por: Baeza, Alejandro
Publicado: (2020) -
Targeting strategies for improving the efficacy of nanomedicine in oncology
por: Villaverde, Gonzalo, et al.
Publicado: (2019) -
Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy
por: Thakur, Neelam, et al.
Publicado: (2020) -
Harnessing Solute Carrier Transporters for Precision Oncology
por: Nyquist, Michael D., et al.
Publicado: (2017) -
Advances in the Use of Immunotherapy in Oncology
por: Olszanski, Anthony J., et al.
Publicado: (2017)